共 50 条
- [1] Indirect Comparisons of Adverse Events and Dropout Rates in Early Parkinson's Disease Trials of Pramipexole, Ropinirole, and RasagilineINTERNATIONAL JOURNAL OF NEUROSCIENCE, 2012, 122 (07) : 345 - 353Zagmutt, Francisco J.Tarrants, Marcy L.
- [2] Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease - An evidence-based comparisonDRUGS & AGING, 2003, 20 (11) : 847 - 855Inzelberg, RSchechtman, ENisipeanu, P
- [3] Comparison of the risk of adverse events with pramipexole and ropinirole in patients with Parkinson's disease - A meta-analysisDRUG SAFETY, 2003, 26 (06) : 439 - 444Etminan, MGill, SSamii, A
- [4] The effectiveness of pramipexole in early and advanced Parkinson's disease and comparison of the results with ropiniroleEUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 668 - 668Karakaya, F.Ozturk, S.Ceviz, I.Kusbeci, O. Yilmaz
- [5] Efficacy of rasagiline monotherapy for Parkinson's disease (PD)ANNALS OF NEUROLOGY, 2005, 58 : S55 - S55Prisco, ULFitzer-Attas, COren, S
- [6] Cabergoline, Pramipexole and Ropinirole Used as Monotherapy in Early Parkinson’s DiseaseAn Evidence-Based ComparisonDrugs & Aging, 2003, 20 : 847 - 855Rivka InzelbergEdna SchechtmanPuiu Nisipeanu
- [7] Comparison of the Risk of Adverse Events with Pramipexole and Ropinirole in Patients with Parkinson’s DiseaseA Meta-AnalysisDrug Safety, 2003, 26 : 439 - 444Mahyar EtminanSudeep GillAli Samii
- [8] COMPARISON OF PRAMIPEXOLE VERSUS ROPINIROLE IN THE TREATMENT OF PARKINSON'S DISEASEIDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2022, 75 (1-2): : 37 - 47Gencler, Onur SerdarOztekin, NeseOztekin, Mehmet Fevzi
- [9] Comparison of combination and monotherapy of rasagiline in Parkinson's diseaseINTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 266 - 266Salek, SamKamudoni, PaulMuhamed, BijuThomas, ChrisRaha, Sandip